Meltz Mark A
Insider CIK 1771329 · BOLD SVP, General Counsel · KNTE COO General Counsel Treasurer · LYEL General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2026-02-10 | 2026-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2025-06-09 | 2025-06-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 121,503 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 215,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 135,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 384,508 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 100,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 27,578 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 558 | $2.59 | $1.4K | 27,578 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-12-01 | 2023-12-05 | 541 | $2.25 | $1.2K | 28,136 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-09-01 | 2023-09-06 | 541 | $2.35 | $1.3K | 28,677 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-06-01 | 2023-06-05 | 541 | $4.30 | $2.3K | 29,218 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-03-01 | 2023-03-03 | 638 | $5.21 | $3.3K | 27,286 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-02-10 | 2023-02-14 | 215,000 | — | $0 | 215,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2022-12-01 | 2022-12-02 | 541 | $7.75 | $4.2K | 27,924 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2022-09-01 | 2022-09-02 | 25,000 | — | $0 | 28,465 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 135,000 | — | $0 | 135,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2021-02-12 | 2021-02-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 104,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 32,705 | $60.00 | $1.96M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-12 | 2019-12-16 | 4,628 | $59.37 | $274.8K | 32,705 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-03-28 | 2019-04-01 | 104,000 | — | $0 | 104,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award | 2019-03-28 | 2019-04-01 | 37,333 | — | $0 | 37,333 | SEC↗ |